Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Barrington Research Initiates Coverage On Orthofix Medical with Outperform Rating, Announces Price Target of $16

Author: Benzinga Newsdesk | June 23, 2025 08:51am
Barrington Research analyst Michael Petusky initiates coverage on Orthofix Medical (NASDAQ:OFIX) with a Outperform rating and announces Price Target of $16.

Posted In: OFIX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist